Effect of amino acid substitutions in the human IFN-γR2 on IFN-γ responsiveness

Genes and Immunity

Volumn 12, Issue 2, 2011, Pages 136-144

  De Paus, R A ^a   Kilic, S S ^b   Van Dissel, J T ^a   Van De Vosse, E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

IFNGR2; immunodeficiency; interferon g; mutation; mycobacterium; polymorphism

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 2; HLA ANTIGEN CLASS 1; INTERCELLULAR ADHESION MOLECULE 1; STAT1 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CELL MEMBRANE; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; CELL LINE, TUMOR; CELL MEMBRANE; HUMANS; INTERFERON-GAMMA; JURKAT CELLS; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC;

CORYNEBACTERINEAE; MYCOBACTERIUM;

EID: 79952281573     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2010.74     Document Type: Article

References (30)

1. Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, Hoeve MA, Sanal O, van Dissel JT. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 2002; 32: 97-105. (Pubitemid 34977203)
2. van de Vosse E, Hoeve MA, Ottenhoff TH. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 2004; 4: 739-749. (Pubitemid 39574345)
3. Valente G, Ozmen L, Novelli F, Geuna M, Palestro G, Forni G et al. Distribution of interferon-gamma receptor in human tissues. Eur J Immunol 1992; 22: 2403-2412.
4. Hu X, Chakravarty SD, Ivashkiv LB. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev 2008; 226: 41-56.
5. Saha B, Jyothi PS, Chandrasekar B, Nandi D. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 2010; 50: 1-14.
6. Bernabei P, Allione A, Rigamonti L, Bosticardo M, Losana G, Borghi I et al. Regulation of interferon-gamma receptor (IFNgammaR) chains: a peculiar way to rule the life and death of human lymphocytes. Eur Cytokine Netw 2001; 12: 6-14. (Pubitemid 32281183)
7. Krause CD, Lavnikova N, Xie J, Mei E, Mirochnitchenko OV, Jia Y et al. Preassembly and ligand-induced restructuring of the chains of the IFN-gamma receptor complex: the roles of Jak kinases, Stat1 and the receptor chains. Cell Res 2006; 16: 55-69. (Pubitemid 43129309)
8. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749-795.
9. Tessitore A, Pastore L, Rispoli A, Cilenti L, Toniato E, Flati V et al. Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule (ICAM-1) gene are required for induction of transcription by IFN-gamma. Eur J Biochem 1998; 258: 968-975. (Pubitemid 29013534)
10. Valente AJ, Xie JF, Abramova MA, Wenzel UO, Abboud HE, Graves DT. A complex element regulates IFN-gamma-stimulated monocyte chemoattractant protein-1 gene transcription. J Immunol 1998; 161: 3719-3728.
11. Clarke DL, Clifford RL, Jindarat S, Proud D, Pang L, Belvisi MG et al. TNFalpha and IFNgamma synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-kappaB and the transcriptional coactivator CREB-binding protein. J Biol Chem 2010; 285: 29101-29110.
12. van den Elsen PJ, Holling TM, Kuipers HF, van der Stoep N. Transcriptional regulation of antigen presentation. Curr Opin Immunol 2004; 16: 67-75. (Pubitemid 38198119)
13. Wang IM, Contursi C, Masumi A, Ma X, Trinchieri G, Ozato K. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol 2000; 165: 271-279. (Pubitemid 30429516)
14. van Boxel-Dezaire AH, Stark GR. Cell type-specific signaling in response to interferon-gamma. Curr Top Microbiol Immunol 2007; 316: 119-154.
15. Gomez JA, Sun W, Gama V, Hajkova D, Yoshida T, Wu Z et al. The C-terminus of interferon gamma receptor beta chain (IFNgammaR2) has antiapoptotic activity as a Bax inhibitor. Cancer Biol Ther 2009; 8: 1771-1786.
16. Regis G, Conti L, Boselli D, Novelli F. IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes. Trends Immunol 2006; 27: 96-101. (Pubitemid 43221976)
17. van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E. Functional analysis of naturally occurring amino acid substitutions in human IFN-gammaR1. Mol Immunol 2010; 47: 1023-1030.
18. Doffinger R, Jouanguy E, Dupuis S, Fondaneche M-C, Stephan J-L, Emile JF et al. Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette- Guerin and Mycobacterium abscessus infection. J Infect Dis 2000; 181: 379-384. (Pubitemid 30049075)
19. Vogt G, Bustamante J, Chapgier A, Feinberg J, Boisson DS, Picard C et al. Complementation of a pathogenic IFNGR2 misfolding mutation with modifiers of N-glycosylation. J Exp Med 2008; 205: 1729-1737.
20. Nakashima H, Inoue H, Akahoshi M, Tanaka Y, Yamaoka K, Ogami E et al. The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett 1999; 453: 187-190. (Pubitemid 29335497)
21. Schrijver HM, Hooper-van Veen T, van Belzen MJ, Crusius JB, Pena AS, Barkhof F et al. Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis. Eur J Immunogenet 2004; 31: 133-140. (Pubitemid 38845118)
22. Gao P-S, Mao X-Q, Jouanguy E, Pallier A, Doffinger R, Tanaka Y et al. Nonpathogenic common variants of IFNGR1 and IFNGR2 in association with total serum IgE levels. Biochem and Biophys Res Comm 1999; 263: 425-429. (Pubitemid 29467212)
23. Rosenzweig SD, Dorman SE, Uzel G, Shaw S, Scurlock A, Brown MR et al. A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol 2004; 173: 4000-4008. (Pubitemid 39280764)
24. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993; 61: 3482-3489. (Pubitemid 23223442)
25. Vogt G, Chapgier A, Yang K, Chuzhanova N, Feinberg J, Fieschi C et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet 2005; 37: 692-700. (Pubitemid 41754885)
26. Heemskerk MH, Blom B, Nolan G, Stegmann AP, Bakker AQ, Weijer K et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med 1997; 186: 1597-1602. (Pubitemid 27479820)
27. van de Vosse E, de Paus RA, van Dissel JT, Ottenhoff THM. Molecular complementation of IL-12Rb1 deficiency reveals functional differences between IL-12Rb1 alleles including partial IL-12Rb1 deficiency. Hum Mol Genet 2005; 14: 3847-3855. (Pubitemid 43020086)
28. Higuchi R, Krummel B, Saiki RK. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 1988; 16: 7351-7367.
29. Kinsella TM, Nolan GP. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996; 7: 1405-1413. (Pubitemid 26293560)
30. Kohlhuber F, Rogers NC, Watling D, Feng J, Guschin D, Briscoe J et al. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol Cell Biol 1997; 17: 695-706. (Pubitemid 27044369)